Outcomes in Radiotherapy-Treated Patients With Cancer During the COVID-19 Outbreak in Wuhan, China

Conghua Xie; Xiaoyong Wang; Hui Liu; Zhirong Bao; Jing Yu; Yahua Zhong; Melvin L K Chua

doi:10.1001/jamaoncol.2020.2783

Outcomes in Radiotherapy-Treated Patients With Cancer During the COVID-19 Outbreak in Wuhan, China

JAMA Oncol. 2020 Sep 1;6(9):1457-1459. doi: 10.1001/jamaoncol.2020.2783.

Authors

Conghua Xie^{1

2

3}, Xiaoyong Wang^{1

2

3}, Hui Liu^{1

2

3}, Zhirong Bao^{1

2

3}, Jing Yu^{1

2

3}, Yahua Zhong^{1

2

3}, Melvin L K Chua^{1

4

5}

Affiliations

¹ Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
² Hubei Key Laboratory of Tumor Biological Behaviors, Zhongnan Hospital of Wuhan University, Wuhan, China.
³ Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, China.
⁴ Division of Radiation Oncology, Division of Medical Sciences, National Cancer Centre Singapore, Singapore.
⁵ Oncology Academic Clinical Programme, Duke-National University of Singapore Medical School, National University of Singapore, Singapore.

Abstract

This case series evaluated the delivery of radiotherapy in 209 patients with cancer during the COVID-19 outbreak in Wuhan, China.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Betacoronavirus / pathogenicity
COVID-19
China / epidemiology
Coronavirus Infections / complications
Coronavirus Infections / epidemiology
Coronavirus Infections / radiotherapy*
Coronavirus Infections / virology
Disease Outbreaks
Female
Humans
Male
Middle Aged
Neoplasms / complications
Neoplasms / epidemiology
Neoplasms / radiotherapy*
Neoplasms / virology
Pandemics*
Pneumonia, Viral / complications
Pneumonia, Viral / epidemiology
Pneumonia, Viral / radiotherapy*
Pneumonia, Viral / virology
SARS-CoV-2
Treatment Outcome